Healthcare provider profile · identity verified

Thomas James Heinitz, M.D.

Family Practice · PROCTOR, MN · NPI 1629022397

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	852	224
Amlodipine Besylate	Amlodipine Besylate	471	120
Lisinopril	Lisinopril	383	104
Omeprazole	Omeprazole	362	86
Losartan Potassium	Losartan Potassium	315	85
Levothyroxine Sodium	Levothyroxine Sodium	298	70
Rosuvastatin Calcium	Rosuvastatin Calcium	261	72
Metoprolol Succinate	Metoprolol Succinate	257	77
Tamsulosin Hcl	Tamsulosin Hcl	252	60
Hydrochlorothiazide	Hydrochlorothiazide	236	70
Gabapentin	Gabapentin	230	48
Metformin Hcl Er	Metformin Hcl	220	52
Sertraline Hcl	Sertraline Hcl	180	44
Simvastatin	Simvastatin	163	45
Famotidine	Famotidine	153	37
Carvedilol	Carvedilol	131	32
Albuterol Sulfate Hfa	Albuterol Sulfate	125	36
Trazodone Hcl	Trazodone Hcl	119	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	112	18
Fluticasone Propionate	Fluticasone Propionate	108	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	107	27
Allopurinol	Allopurinol	101	27
Oxybutynin Chloride Er	Oxybutynin Chloride	100	14
Eliquis	Apixaban	98	23
Metoprolol Tartrate	Metoprolol Tartrate	96	27
Jardiance	Empagliflozin	95	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	95	18
Lorazepam	Lorazepam	94	24
Xarelto	Rivaroxaban	88	20
Prednisone	Prednisone	86	43
Warfarin Sodium	Warfarin Sodium	86	26
Ozempic	Semaglutide	82	15
Metformin Hcl	Metformin Hcl	75	22
Pantoprazole Sodium	Pantoprazole Sodium	75	15
Zolpidem Tartrate	Zolpidem Tartrate	71	16
Furosemide	Furosemide	70	22
Celecoxib	Celecoxib	65	16
Duloxetine Hcl	Duloxetine Hcl	65	19
Finasteride	Finasteride	65	17
Alendronate Sodium	Alendronate Sodium	64	19
Pravastatin Sodium	Pravastatin Sodium	64	19
Tramadol Hcl	Tramadol Hcl	63	11
Trulicity	Dulaglutide	61	11
Ventolin Hfa	Albuterol Sulfate	61	19
Bupropion Xl	Bupropion Hcl	59	14
Spironolactone	Spironolactone	58	15
Montelukast Sodium	Montelukast Sodium	56	13
Atenolol	Atenolol	53	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	53	16
Escitalopram Oxalate	Escitalopram Oxalate	51	16
Chlorthalidone	Chlorthalidone	49	13
Mounjaro	Tirzepatide	49	suppressed
Pregabalin	Pregabalin	49	12
Tizanidine Hcl	Tizanidine Hcl	49	14
Potassium Chloride	Potassium Chloride	48	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	14
Pioglitazone Hcl	Pioglitazone Hcl	46	suppressed
Valsartan	Valsartan	46	11
Citalopram Hbr	Citalopram Hydrobromide	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Estradiol	Estradiol	43	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	suppressed
Propranolol Hcl Er	Propranolol Hcl	42	suppressed
Spiriva Handihaler	Tiotropium Bromide	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Ibuprofen	Ibuprofen	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	suppressed
Clonazepam	Clonazepam	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Fenofibrate	Fenofibrate	35	suppressed
Nitroglycerin	Nitroglycerin	35	25
Solifenacin Succinate	Solifenacin Succinate	35	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	34	suppressed
Torsemide	Torsemide	34	suppressed
Aripiprazole	Aripiprazole	33	suppressed
Baclofen	Baclofen	32	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	32	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Glimepiride	Glimepiride	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Topiramate	Topiramate	28	suppressed
Alprazolam	Alprazolam	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Ketoconazole	Ketoconazole	26	13
Morphine Sulfate	Morphine Sulfate	26	suppressed
Lactulose	Lactulose	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Amoxicillin	Amoxicillin	24	15
Levetiracetam	Levetiracetam	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Azithromycin	Azithromycin	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	14
Lamotrigine	Lamotrigine	21	suppressed
Ramipril	Ramipril	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Testosterone	Testosterone	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Eszopiclone	Eszopiclone	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	11
Hydrocortisone	Hydrocortisone	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Nystatin	Nystatin	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Dulera	Mometasone/Formoterol	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Temazepam	Temazepam	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Constulose	Lactulose	14	suppressed
Dupixent Syringe	Dupilumab	14	suppressed
Fluocinonide	Fluocinonide	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Belsomra	Suvorexant	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
M-Natal Plus	Pnv,calcium 72/Iron/Folic Acid	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Novolin N	Insulin Nph Human Isophane	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error